Barriers to hormone replacement therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers

被引：0
|
作者：
DiSilvestro, J. B. [1 ]
Haddad, J. [1 ]
Robison, K. M. [1 ]
Beffa, L. B. [1 ]
Laprise, J. [1 ]
Wilbur, J. Scalia [1 ]
Raker, C. [1 ]
Hofstatter, E. [2 ]
Dalela, D. [2 ]
Brown, A. K. [3 ]
Bradford, L. [4 ]
Toland, M. [5 ]
Stuckey, A. R. [1 ]
机构：
[1] Brown Univ, Women & Infants Hosp, Providence, RI USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Hartford Hosp, Hartford, CT 06115 USA
[4] Univ Massachusetts, Med Ctr, Worcester, MA USA
[5] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
560
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
    DiSilvestro, Jessica B.
    Haddad, Jessica
    Robison, Katina
    Beffa, Lindsey
    Laprise, Jessica
    Scalia-Wilbur, Jennifer
    Raker, Christina
    Clark, Melissa
    Lokich, Elizabeth
    Hofstatter, Erin
    Dalela, Disha
    Brown, Amy
    Bradford, Leslie
    Toland, Maris
    Stuckey, Ashley
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (07): : 732 - 737
  • [2] Prophylactic bilateral mastectomy and bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
    Haddad, Jessica
    Beffa, Lindsey
    Robison, Katina
    Gass, Jennifer
    Legare, Robert
    Laprise, Jessica
    Scalia-Wilbur, Jennifer
    Raker, Christina
    Clark, Melissa
    Stuckey, Ashley
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 65 - 65
  • [3] Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
    Bradbury, Angela R.
    Ibe, Comfort. N.
    Dignam, James J.
    Cummings, Shelly A.
    Verp, Marion
    White, Melody A.
    Artioli, Grazia
    Dudlicek, Laura
    Olopade, Olufunmilayo L.
    GENETICS IN MEDICINE, 2008, 10 (03) : 161 - 166
  • [4] Can bilateral prophylactic salpingo-oophorectomy reduce cancer mortality in carriers of a BRCA1 or BRCA2 mutation?
    Brekelmans, CTM
    Seynaeve, C
    LANCET ONCOLOGY, 2006, 7 (03): : 191 - 193
  • [5] Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers
    Madalinska, Joanna B.
    van Beurden, Marc
    Bleiker, Eveline M. A.
    Valdimarsdottir, Heiddis B.
    Lubsen-Brandsma, Lottie
    Massuger, Leon F.
    Mourits, Marian J. E.
    Gaarenstroom, Katja N.
    van Dorst, Eleonora B. L.
    van der Putten, Hans
    Boonstra, Henk
    Aaronson, Neil K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 301 - 307
  • [6] Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?
    Vyarvelska, Iryna
    Rosen, Barry
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 219 - 221
  • [7] Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers
    Biglia, N.
    Mariani, L.
    Ponzone, R.
    Sismondi, P.
    MATURITAS, 2008, 60 (02) : 71 - 77
  • [8] Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
    Kara N. Maxwell
    Susan M. Domchek
    Current Breast Cancer Reports, 2012, 4 (3) : 199 - 206
  • [9] Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
    Maxwell, Kara N.
    Domchek, Susan M.
    CURRENT BREAST CANCER REPORTS, 2012, 4 (03) : 199 - 206
  • [10] Estrogens and Cognition in BRCA1/2 Mutation Carriers Following Prophylactic Salpingo-Oophorectomy (Oct, pg 522, 2010)
    Schwartz, Deborah
    Finch, Amy
    Tierney, Mary
    Hampson, Elizabeth
    Narod, Steven
    Einstein, Gillian
    GENDER MEDICINE, 2011, 8 (01) : 56 - 56
12345